•Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer
•Biomarker testing for carcinomas of the upper gastrointestinal tract
•The Cost-effectiveness of Gastric Cancer Screening and Surveillance Among Average-risk and Risk-stratified Populations
•Expression of concern: The design and synthesis of redox-responsive oridonin polymeric prodrug micelle formulation for effective gastric cancer therapy
•The Duality of Cdk5: A Master Regulator in Neurodevelopment and a Hijacked Oncogene in Cancer